Upcoming events
Discovery on Target
In person
ZoBio will participate in Discovery on Target, the industry’s premier event focused on novel drug targets and cutting-edge technologies for drug discovery professionals. The conference always showcase the latest advancements in both current and emerging “hot” targets, as well as innovative target validation strategies for developing novel therapeutic agents, from biologics to small molecules.
Gregg Siegal | LinkedIn, CEO of ZoBio, will present the poster titled Biophysics-driven Molecular Glue Discovery.
Have a drug discovery challenge? Let’s talk about how we can help move your project forward.
16th Swiss Course on Medicinal Chemistry in Leysin
In person
As in previous years, ZoBio is proud to be part of the 16th Swiss Course on Medicinal Chemistry in Leysin!
This five-day Medicinal Chemistry School, organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society , focuses on the most cutting-edge aspects of small molecule drug discovery, highlighting methodologies and technologies that support hit generation, lead finding, and lead optimization campaigns.
Also our scientists are excited to contribute to this special event. On Thursday, October 8th, Stephan Theisgen | LinkedIn will present a talk on the application of NMR in modern drug discovery. Additionally, Marta G. Carneiro | LinkedIn (Head of Structural Biology) and Johan Veerman | LinkedIn (Head of Chemistry) will share their expertise on the use of biophysics in various aspects of drug discovery with the next generation of drug hunters.
Looking forward to meeting you in Leysin!
Developments in Protein Interaction Analysis (DiPIA 2026)
In person
Our colleagues Henri van Son and Ronald Jean-Baptiste will represent ZoBio team at the DIPIA Conference hosted by Cytiva. This event brings together industry peers to share best practices, research, and new applications in the field. The conference is specifically dedicated to surface plasmon resonance (SPR) technology.. Henri and Ronald will present two posters highlighting the potential of tailored SPR assays for studying molecular interactions and supporting the development of new approaches in drug discovery.
Henri van Son will present:
“Advancing Molecular Interaction Analysis with Tailored SPR Assays”
Ronald Jean-Baptiste will present:
“Development of SPR Assay to Support Hit to Lead Drug Discovery for Phosphatases”
A great opportunity to share our research, exchange ideas, and connect with colleagues from the scientific community!
ELRIG (Drug Discovery 2026)
In person
One of our ADS scientists, Welmoet de Winter will represent our team at the upcoming ELRIG Conference, where she will present the research of our team on site-selective screening and fragment-based drug discovery.
Her poster: “Site-selective screening: Design, synthesis and application of stable S-adenosylmethionine-based probes for fragment screening against METTL3/14” focuses on the design and application of stable S-adenosylmethionine-based probes to support site-selective fragment screening against METTL3/14.
We look forward to seeing our research represented at the conference and to engaging with colleagues from the drug discovery community.
Good luck, Welmoet!